Drug Type Autologous CAR-T |
Synonyms GB 3015, GB-3015 |
Target |
Mechanism EBV Protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nasopharyngeal Carcinoma | Preclinical | CN | 30 Jan 2022 | |
Nasopharyngeal Neoplasms | Preclinical | - | - |